A drug‑resistant fungus that can survive on surfaces for weeks and spread in healthcare settings has been confirmed in 23 U.S. states, but federal data indicate the greatest risk remains inside hospitals and long‑term care facilities rather than in the wider community.
The fungus, known as Candida auris, has drawn attention from health officials because some strains can resist multiple classes of antifungal medicines, making infections harder to treat. The Centers for Disease Control and Prevention (CDC) classifies C. auris as an urgent public health threat because of its ability to spread in healthcare environments and cause severe infections among vulnerable patients.
